Hamborner REIT AG
LSE:0MCG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hamborner REIT AG
LSE:0MCG
|
DE |
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
Polycab India Ltd
NSE:POLYCAB
|
IN |
|
Canafarma Hemp Products Corp
F:4K9
|
CA |
Wall St Price Targets
0MCG Price Targets Summary
Hamborner REIT AG
According to Wall Street analysts, the average 1-year price target for 0MCG is 9.107 EUR with a low forecast of 7.687 EUR and a high forecast of 11.986 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0MCG's stock price target?
Price Target
9.107
EUR
According to Wall Street analysts, the average 1-year price target for 0MCG is 9.107 EUR with a low forecast of 7.687 EUR and a high forecast of 11.986 EUR.
What is the Revenue forecast for Hamborner REIT AG?
Projected CAGR
3%
Over the last 8 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 5 years is 3%.
What is the Gross Profit forecast for Hamborner REIT AG?
Projected CAGR
1%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 5 years is 1%.
What is the Operating Income forecast for Hamborner REIT AG?
Projected CAGR
-21%
Over the last 8 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 5 years is -21%.
What is the Pre-Tax Income forecast for Hamborner REIT AG?
Projected CAGR
-31%
Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 2 years is -31%.
What is the Net Income forecast for Hamborner REIT AG?
Projected CAGR
-11%
Over the last 8 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 5 years is -11%.
